<SEC-DOCUMENT>0001104659-23-043709.txt : 20231115
<SEC-HEADER>0001104659-23-043709.hdr.sgml : 20231115
<ACCEPTANCE-DATETIME>20230410193821
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001104659-23-043709
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230410

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Data Knights Acquisition Corp.
		CENTRAL INDEX KEY:			0001849380
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				862076743
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		TRIDENT COURT, 1 OAKCROFT ROAD
		STREET 2:		CHESSINGTON
		CITY:			SURREY
		STATE:			X0
		ZIP:			KT9 1BD
		BUSINESS PHONE:		011-44-208-090-2009

	MAIL ADDRESS:	
		STREET 1:		TRIDENT COURT, 1 OAKCROFT ROAD
		STREET 2:		CHESSINGTON
		CITY:			SURREY
		STATE:			X0
		ZIP:			KT9 1BD

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Data Knights Acquisition Corp.
		DATE OF NAME CHANGE:	20210304
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="1" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt; color: Black">&nbsp;<B><IMG SRC="tm2220656d21_corresimg001.jpg" ALT="" STYLE="height: 29px; width: 252px"></B></FONT></P></TD>
    <TD STYLE="width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #355989"><FONT STYLE="font-size: 10pt; color: Black"><B>&nbsp;</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #355989"><FONT STYLE="font-size: 10pt; color: Black"><B>NELSON
    MULLINS RILEY&nbsp;&amp; SCARBOROUGH LLP</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #689ac5"><FONT STYLE="font-size: 10pt; color: Black"><B>ATTORNEYS
    AND COUNSELORS AT LAW</B></FONT></P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #485667"><FONT STYLE="font-size: 10pt; color: Black">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #485667"><FONT STYLE="font-size: 10pt; color: Black">Larry
    Shackelford<BR>
    T: 404.322.6173</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #485667"><FONT STYLE="font-size: 10pt; color: Black"><B>larry.shackelford@nelsonmullins.com
    </B></FONT></P></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #485667"><FONT STYLE="font-size: 10pt; color: Black">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #485667"><FONT STYLE="font-size: 10pt; color: Black">201
    17th Street NW, Suite&nbsp;1700</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #485667"><FONT STYLE="font-size: 10pt; color: Black">Atlanta,
    GA 30363</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #485667"><FONT STYLE="font-size: 10pt; color: Black">T:
    404.322.6000 F: 404.322.6050</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #485667"><FONT STYLE="font-size: 10pt; color: Black"><B>nelsonmullins.com</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">April&nbsp;10, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Via EDGAR</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Division of Corporation Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">Securities and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 F Street, N.E.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Washington, DC 20549</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.7in">Attention:</TD><TD>Ms.&nbsp;Taylor Beech<BR>
Ms.&nbsp;Erin Jaskot</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">RE:</TD><TD>Data Knights Acquisition Corp.<BR>
Amendment No.&nbsp;5 to Registration on Form&nbsp;S-4<BR>
Filed April&nbsp;7, 2023<BR>
File No.&nbsp;333-266274</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On behalf of Data Knights Acquisition Corp. (the
 &ldquo;Company&rdquo;), we are hereby responding to the letter dated February&nbsp;17, 2023 (the &ldquo;Fifth Comment Letter&rdquo;) from
the staff (the &ldquo;Staff&rdquo;) of the Securities and Exchange Commission (&ldquo;SEC&rdquo; or the &ldquo;Commission&rdquo;), regarding
the Company&rsquo;s Amendment No.&nbsp;4 to Registration Statement on Form&nbsp;S-4 filed February&nbsp;3, 2023 (the &ldquo;Registration
Statement&rdquo;). In response to the Fifth Comment Letter and to update certain information in the Registration Statement, the Company
is submitting its Amendment No.&nbsp;5 to the Registration Statement (the &ldquo;Amended Registration Statement&rdquo;) with the Commission
today.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capitalized terms used but not defined in this
letter have the meanings as defined in the Amended Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For ease of reference, the text of the Staff&rsquo;s
comment is included in bold-face type below, followed by the Company&rsquo;s response.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>California
| Colorado | District of Columbia | Florida | Georgia | Maryland | Massachusetts</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>Minnesota
| New York | North Carolina | Ohio | South Carolina | Tennessee | Texas | Virginia | West Virginia</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April&nbsp;10, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page&nbsp;2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Questions and Answers About the Proposals</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Q. How Does the Sponsor Intend to Vote on
the Proposals?, page&nbsp;10</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>1.</I></B></TD><TD STYLE="text-align: justify"><B><I>We note your response to comment 13 and reissue our comment in part. It appears that your disclosure
on page&nbsp;10 which states that &quot;the Insiders own of record and are entitled to vote an aggregate of approximately 20% of the outstanding
shares of Data Knights Class&nbsp;A Common Stock through their ownership of Founder Shares,&quot; includes shares held by PIPE investors.
Given that PIPE investors will not be voting on the Proposals, please revise to present the Insiders' ownership prior to the PIPE investment
or any other alternative financing.</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Response:</B> The Amended Registration Statement
has been revised on page&nbsp;11 to correct the percentage of the outstanding shares of Data Knights Common Stock which may be voted
by the Insiders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Q. How do redemptions of Data Knights' Public
Shares impact the Closing..., page&nbsp;20</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>2.</I></B></TD><TD STYLE="text-align: justify"><B><I>We reissue comment 3 in part. Please clarify, to the extent accurate, that non-redemption agreements
would not be sufficient to ensure you meet the Minimum Cash Condition.</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Response:</B> The Amended Registration Statement
has been revised on page&nbsp;20 to disclose that non-redemption agreements would not be sufficient to ensure that the Company satisfies
the Minimum Cash Condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><B><U>Unaudited
Pro Forma Condensed Combined Financial Information, page&nbsp;46</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>3.</I></B></TD><TD STYLE="text-align: justify"><B><I>Rule&nbsp;11-01(a)(8)&nbsp;of Regulation S-X requires transactions to be probable to be included
in pro forma financial information. Therefore, if consummation of the PIPE is not probable, please remove this pro forma adjustment.</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Response:</B> In response to SEC&rsquo;s comment,
the pro forma financial information has been revised to remove this pro forma adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><B><U>OneMedNet
Management's Discussion and Analysis of Financial Condition and Results of Operations, page&nbsp;184</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>4.</I></B></TD><TD STYLE="text-align: justify"><B><I>We note the revised disclosure in response to comment 11. However, this disclosure should be provided
in MD&amp;A of OneMedNet, which starts on page&nbsp;184, rather than in the notes to the financial statements. Please revise to move the
added disclosure to MD&amp;A. Please also revise the table of contents at the beginning of your filing to include MD&amp;A.</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Response:</B> We acknowledge the Staff&rsquo;s
comment and have updated the Registration Statement accordingly, including updating OneMedNet&rsquo;s MD&amp;A and removing the prior
information inserted in the financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April&nbsp;10, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page&nbsp;3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><B><U>Executive
Compensation of OneMedNet Outstanding Equity Awards, page&nbsp;198</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>5.</I></B></TD><TD STYLE="text-align: justify"><B><I>We note your disclosure that OneMedNet has no outstanding equity awards, yet we also note that your
summary compensation table suggests equity awards were granted in each of the last three fiscal years. Please confirm that there were
no equity awards outstanding as of December&nbsp;31, 2022, or provide the disclosure required by Item 402(p).</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Response: </B>In response to the Staff&rsquo;s
comment, we have amended the disclosure on page&nbsp;200 of the Registration Statement provide the disclosure required by Item 402(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Exhibits</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>6.</I></B></TD><TD STYLE="text-align: justify"><B><I>We note your response to comment 10 that you have redacted the names of the parties to exhibits
10.18 and 10.19 because they are confidential. However, we do not see that the exhibit index or exhibits contain the disclosure required
by Item 601(b)(10)(iv)&nbsp;indicating that you are redacting certain terms, and the redacted terms are not marked in the agreement. To
the extent you wish to redact terms that are both not material and are the type that you treat as private and confidential, please revise
to follow the procedure set forth in Item 601(b)(10)(iv). In the alternative, please file unredacted copies of these agreements.</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Response: </B>In response to the Staff&rsquo;s
comment, we have amended the index and exhibits to contain the disclosure required by Item 601(b)(10)(iv).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>General</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>7.</I></B></TD><TD STYLE="text-align: justify"><B><I>We note your disclosure on page&nbsp;20 that there has been a slowdown in PIPE investments and that
you are in negotiations with an investor regarding a SEPA for funds totaling $50 million to $100 million over 36 months. Given that you
are pursuing alternative funding options in place of the PIPE, please tell us why you believe it is appropriate to continue presenting
the disclosure throughout the registration statement as if the PIPE will occur, such as in the ownership disclosure both before and after
the Business Combination, the Nasdaq Proposal which relates only to the issuance of shares in connection with a PIPE, and that the common
stock issued and outstanding assumes no additional equity financing other than the PIPE. In addition, the discussions of the risks of
a failure to complete the PIPE investment suggests that the PIPE financing is the only funding source you are pursuing. In the alternative,
please revise the disclosure throughout so the following is clear to investors:</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The various financing alternatives you
are pursuing;</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April&nbsp;10, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page&nbsp;4</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The likelihood that such financing is secured
and the anticipated timing;</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>A summary of the material terms of such
financing, to the extent known;</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Whether you would issue shares at a discount,
including a risk factor indicating that shares issued at a discount could result in negative pressure on your stock price following the
Business Combination;</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Whether and to what extent the PIPE and/or
SEPA may be a possible source of dilution for shareholders who elect not to redeem their shares in connection with the business combination.
To the extent that it may be a significant source of dilution, please provide disclosure of the impact of that significant source of dilution
at each of the redemption levels detailed in your sensitivity analysis, including any needed assumptions; and</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Revise the Background of the Business Combination
section beginning on page&nbsp;107 to include a discussion of negotiations relating to the SEPA, including background on when and why
you decided to pursue this additional financing arrangement and the status of such arrangements.</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Response:</B> In response to the Staff&rsquo;s
comment, we have revised the disclosure in the Amended Registration Statement to discuss the financing alternatives being pursued, to
make clear that obtaining such financing cannot be assured, and further disclose the potential impacts of the financing alternatives on
the Company&rsquo;s stock price and the dilution experienced by the Public Shareholders who elect not to redeem their shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>8.</I></B></TD><TD STYLE="text-align: justify"><B><I>Please include disclosure addressing the risk that you may be deemed to be an investment company
under the U.S. Investment Company Act of 1940 that is comparable to the risk factor disclosure on pages&nbsp;24-25 of your Definitive
Proxy Statement on Schedule 14A filed on October&nbsp;27, 2022.</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Response:</B> The Amended Registration Statement
has been revised on pages&nbsp;76 and 77 to add the requested disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">* &#8239;&#8239;*&#8239;&#8239; *&#8239;&#8239; *&#8239;&#8239; *</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Given the Company&rsquo;s time constraints to
complete the Business Combination, we would be very appreciative of the Staff&rsquo;s expeditious review of the Company&rsquo;s responses
and updates to the Amended Registration Statement. Please contact me with any questions or follow up requests. I can be reached at 404-322-6713
or larry.shackelford@nelsonmullins.com. Thank you very much for your assistance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 49%"></TD><TD STYLE="width: 2%; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify; width: 49%">Sincerely,</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">Larry Shackelford</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2220656d21_corresimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2220656d21_corresimg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  = /P# 2(  A$! Q$!_\0
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M>PG$T2N4+ $88=1S]:GN;J&RMGN+F5(H8QEG<X %*P$M%<[!X\\.W%P(4U)
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M5BW ;0.<CT%9C_\ (]?]O0_E6GX5TTV5[*YEW[HL8VX[_6HVTLGQ7]I\X?\
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6>S^TZI))>W=PQE>5OEZ]L4.UKL#_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
